Bioethics.net

July 10, 2014 4:02 pm

Did Facebook and PNAS violate human research protections in an unethical experiment?

Whatever good and bad things about Facebook there are, however, there’s one thing that I never expected the company to be engaging in, and that’s unethical human subjects research.

April 2, 2014 2:17 pm

Guidance published on informing study participants about findings with potential health implications

In the course of a study involving human participants, it is possible that researchers may make a finding that has potential health or reproductive implications for an individual participant.

March 3, 2014 4:08 pm

Women Still Left Out of Medical Research: Report

Two decades after the passage of a landmark law mandating that women be represented in government-funded medical research, a new report reveals that the world of science is still ignoring women’s unique health issues far more than it should.

August 26, 2013 12:56 pm

Reporting to NIH on Race and Ethnicity of Clinical Research Participants

The inclusion of women, different racial and ethnic groups, and children is extremely important in clinical research to understand who is affected by a given disease or condition and to develop the appropriate treatments.

March 20, 2013 5:51 pm

Stanford bioethicist speaks out about layers of stem cell regulations

Stanford bioethicist Hank Greely, JD, spoke out in an article in Nature exploring whether all these layers of approval are really still necessary.

March 7, 2013 12:19 pm

Time to ditch stand-alone stem cell oversight panels, experts say (Nature Medicine)

The vital role ESCROs have played in recent years can now be taken over by IRBs and IACUCs—both of which have existed at universities and research institutions for decades. Those two review bodies would only have to expand their remits slightly to cover hESC-specific considerations.

April 10, 2012 12:18 pm

'Benefits and burdens' of participating in clinical research trials (News-Medical)

In one of the first studies of its kind, University of Pennsylvania School of Nursing researchers have identified what cancer patients consider the “benefits and burdens” of participating in clinical research trials. From their findings, the researchers developed a model of the five elements of decision-making (physical, psychological, economic, familial, and social) that patients with cancer use to determine whether to participate or remain in a clinical trial.

January 18, 2012 12:00 am

Fines expose failings in policing of Indian drug trials

June 23, 2010 12:00 am

EPA Reverses Controversial ?Human Guinea Pig? Rule

June 22, 2010 12:00 am

Concern Over Foreign Trials for Drugs Sold in U.S.